Submit Your Article CMED MEACR meeting
Home Print this page Email this page Users Online: 392
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Clinical outcome and pattern of recurrence in patients with triple negative breast cancer as compared with non-triple negative breast cancer group

Saha Aramita, Chattopadhyay Subrata, Azam Mohammad, Sur Prabir K

Year : 2012| Volume: 1| Issue : 4 | Page no: 201-205

   This article has been cited by
1 Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
Atika Dogra,Anurag Mehta,Dinesh Chandra Doval
Journal of Oncology. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
2 Exploring specific prognostic biomarkers in triple-negative breast cancer
Chang Bao,Yunkun Lu,Jishun Chen,Danni Chen,Weiyang Lou,Bisha Ding,Liang Xu,Weimin Fan
Cell Death & Disease. 2019; 10(11)
[Pubmed]  [Google Scholar] [DOI]
3 miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer
Hao-Yi Li,Jui-Lin Liang,Yao-Lung Kuo,Hao-Hsien Lee,Marcus J. Calkins,Hong-Tai Chang,Forn-Chia Lin,Yu-Chia Chen,Tai-I Hsu,Michael Hsiao,Luo-Ping Ger,Pei-Jung Lu
Breast Cancer Research. 2017; 19(1)
[Pubmed]  [Google Scholar] [DOI]
4 Combination Electrochemotherapy: Another Solution for Triple Negative Breast Cancers
Raji Sundararajan
Journal of Cancer Prevention & Current Research. 2015; 3(5)
[Pubmed]  [Google Scholar] [DOI]


Read this article